-
Amanta Healthcare Analyst Review 2027: Profit Up Fourfold as the Stock Nears Its High
- November 19, 2026
- Posted by: Ankit Jaiswal
- Category: Market
No Comments
Amanta Healthcare grew Q2 FY27 revenue 17% to ₹83.13 crore with EBITDA margin of 21.6%, and profit rose to ₹4.86 crore from ₹1.21 crore. With no brokerage coverage, we review the IV fluids and sterile injectables business, valuation, debt and risks for 2027.